Lucy Ann Godley

Lucy Godley practices at Northwestern Medical Group in Chicago, Illinois.

Lucy Godley's NPI, 1720141245, was assigned on December 18, 2006. Lucy Godley graduated from Harvard Medical School in 1988. Lucy Godley holds Illinois license 036100580.

Lucy Godley's primary practice is Northwestern Medical Group, at 675 N Saint Clair St Ste 19-100 Suite 19-100, Chicago, IL 60611. The practice phone is (312) 664-3278.

Lucy Godley's primary practice is Northwestern Medical Group in Chicago, Illinois. Lucy Godley is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Lucy Godley to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lucy Godley practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Lucy Godley's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Lucy Godley is licensed in Illinois.

CMS data shows 13,241 Medicare services from Lucy Godley across 24 procedure codes in 2024, for 277 Medicare patients. Medicare paid $323,603 for them.

CMS counts 277 Medicare patients who saw Lucy Godley in 2024. The largest group is 65 to 74, with 136 patients. 73% of them have high cholesterol, and 68% have high blood pressure. 8% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Lucy Godley's median patient age at 65, with 52% women.

In 2024, Lucy Godley wrote 129 Medicare Part D claims for 16 patients. 45% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $259,593 in total drug cost. In 2023, CMS named 31 claims across 2 drugs.

Lucy Godley accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lucy Godley as offering telehealth. CMS counts 49 procedures of skin biopsy by Lucy Godley, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 186 papers to Lucy Godley, published from 2010 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Genetic Predisposition to Disease, Germ-Line Mutation and Hematologic Neoplasms. Lucy Godley has published most often in Blood. Lucy Godley's most frequent co-authors are Richard A. Larson, Olatoyosi M. Odenike and Michael W. Drazer, MD.

Dmand AI links Lucy Godley to 2 clinical trials. Conditions studied include Anemia, Refractory, with Excess of Blasts, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma and Anemia, Refractory.

CMS Open Payments shows 6 general payments to Lucy Godley from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $135.

Lucy Godley graduated from Harvard Medical School in 1988.